evidence table
Omega 3 Triglycerides Meta-Analysis Evidence Table
Structured evidence table for Omega 3 Triglycerides Meta-Analysis, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Omega 3 Triglycerides Meta-Analysis | Conclusion In adults with HIV, omega-3 supplementation was associated with small, insignificant increases in HDL-C and meaningful reductions in triglycerides, whereas effects on other lipid fractions were inconsistent. | 1 | Bai J (2026) | Effect of omega-3 supplementation on metabolic and inflammatory markers in adults with HIV infection: a systematic review and meta-analysis. |
| Omega 3 Triglycerides Meta-Analysis | Omega-3 supplementation was associated with a consistent reduction in CRP and modest improvements in other inflammatory biomarkers such as IL-6, while evidence for TNF- α remains inconclusive. | 1 | Bai J (2026) | Effect of omega-3 supplementation on metabolic and inflammatory markers in adults with HIV infection: a systematic review and meta-analysis. |
| Omega 3 Triglycerides Meta-Analysis | Background People living with human immunodeficiency virus (HIV) infection frequently exhibit altered lipid profiles and persistent inflammation that contribute to long-term morbidity. | 1 | Bai J (2026) | Effect of omega-3 supplementation on metabolic and inflammatory markers in adults with HIV infection: a systematic review and meta-analysis. |
| Omega 3 Triglycerides Meta-Analysis | Omega-3 fatty acids are commonly recommended in this population, but the magnitude and consistency of their benefits remain uncertain. | 1 | Bai J (2026) | Effect of omega-3 supplementation on metabolic and inflammatory markers in adults with HIV infection: a systematic review and meta-analysis. |
| Omega 3 Triglycerides Meta-Analysis | However, conventional soybean oil-based emulsions, which are rich in omega-6 fatty acids, are associated with a risk of exacerbating pro-inflammatory responses and immunosuppression, which is of particular importance in critically ill patients. | 4 | Kęska M (2026) | Fish Oil-Containing Injectable Lipid Emulsions in Parenteral Nutrition: Immunomodulation and Clinical Outcomes in Critically Ill Patients-Narrative Review. |
| Omega 3 Triglycerides Meta-Analysis | The cited meta-analyses and clinical studies indicate that omega-3-containing emulsions may reduce the risk of infections and sepsis; shorten hospital stay, ICU length of stay, and duration of mechanical ventilation in patients with sepsis; as well as improve outcomes in acute pancreatitis; lower the risk of delirium; and reduce the incidence of delayed gastric emptying. | 4 | Kęska M (2026) | Fish Oil-Containing Injectable Lipid Emulsions in Parenteral Nutrition: Immunomodulation and Clinical Outcomes in Critically Ill Patients-Narrative Review. |
| Omega 3 Triglycerides Meta-Analysis | Conclusions Available data support the use of mixed-oil ILE supplemented with fish oil in the parenteral nutrition of critically ill patients as a strategy with immunomodulatory and pro-resolving potential that may translate into improved clinical outcomes. | 4 | Kęska M (2026) | Fish Oil-Containing Injectable Lipid Emulsions in Parenteral Nutrition: Immunomodulation and Clinical Outcomes in Critically Ill Patients-Narrative Review. |
| Omega 3 Triglycerides Meta-Analysis | Background and aims Injectable lipid emulsions are an integral component of parenteral nutrition, providing energy as well as essential fatty acids. | 4 | Kęska M (2026) | Fish Oil-Containing Injectable Lipid Emulsions in Parenteral Nutrition: Immunomodulation and Clinical Outcomes in Critically Ill Patients-Narrative Review. |
Source documents